health economics and health care management

Font size »A . A+ . A++ .

RESEARCH GROUP "HEALTH CARE MANAGEMENT":

Postal address:

Helmholtz Zentrum München
German Research Center for Environmental Health
Institute of Health Economics and Health Care Management (IGM)
P.O.Box 1129
D-85758 Neuherberg
Germany
Tel.: +49-89 / 3187-4161
Fax: +49-89 / 3187-3375
eMail:  

 

 

Dr. Björn Stollenwerk, statistician

Position:

Deputy Head of the Research Group

 

Education:

  • degree in statistics (i.e. “Diplom-Statistiker”), subsidiary subject economics, at the University of Dortmund, Germany
  • PhD in statistics, Faculty of Statistics, University of Dortmund, Germany

 

Work experience:

  • Research Fellow at the Institute of Health Economics and Clinical Epidemiology, University of Cologne, Germany
  • Postdoctoral research fellow at the Department of Public Health, Medical Decision Making and Health Technology Assessment, UMIT – University for Health Sciences, Medical Informatics and Technology, Hall in Tyrol/Innsbruck, Austria
  • Postdoctoral research fellow at the Institute of Health Economics and Health Care Management; Helmholtz Zentrum München – German Research Center for Environmental Health, Neuherberg/München, Germany

 

Research Interests:

  • Health Economic Evaluation
  • Decision-Analytic Modelling
  • Biostatistics and Epidemiology

 

Scientific Board Positions:

  • Co-Chair Working Group "Systematic Reviews", German Society of Medical Informatics, Biometry and Epidemiology (GMDS)
  • Secretary Working Group “Health Economics”, German Society of Medical Informatics, Biometry and Epidemiology (GMDS)

 

Affiliations:

  • German Society of Health Economics (DGGÖ)
  • International Biometric Society (IBS)
  • German Society for Medical Informatics, Biometry and Epidemiology (GMDS)
  • GMDS Working Groups “Health Technology Assessment”, “Medical Decision Making”, “Methods of Systematic Reviews” and “Health Economics”
  • Alumni Association of Statisticians of the University of Dortmund

 

Recent publications:

  • Geiger-Gritsch S, Stollenwerk B, Miksad R, Guba B, Wild C, Siebert U. Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials. Oncologist. 15, 1179-1191 (2010)
  • Becker C, Leidl R, Stollenwerk B: Entscheidungsanalytische Modellierung in der ökonomischen Evaluation [Decision-Analytic Modelling in Economic Evaluation]. Gesundheitsökonomie & Qualitätsmanagement 15(5), 260-264 (2010)
  • Grander W, Dunser M, Stollenwerk B, Siebert U, Dengg C, Koller B, Eller P, Tilg H.: CRP Levels and Post-Intensive Care Unit Mortality in Non-Surgical Intensive Care Patients. CHEST. Published online Feb. 2010.
  • Schnell-Inderst P, Schwarzer R, Göhler A, Grandi N, Grabein K, Stollenwerk B, Manne J, Klauss V, Siebert U, Wasem J: Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: A health technology assessment report. International Journal of Technology Assessment in Health Care 26(1), 30-39 (2010)
  • Stock S, Schmidt H, Büscher G, Gerber A, Drabik A, Graf C, Lüngen M, Stollenwerk B: Financial incentives in the German Statutory Health Insurance: New findings, new questions. Health Policy. 96(1), 51-56 (2010)
  • Stollenwerk B, Stock S, Siebert U, Lauterbach KW, Holle R: Uncertainty Assessment of Input Parameters for Economic Evaluation: Gauss’s Error Propagation, an Alternative to Established Methods. Medical Decision Making 30, 304-313(2010)
  • Stollenwerk B, Gerber A, Lauterbach KW, Siebert U: The German Coronary Artery Disease Risk Screening Model: development, validation and application of a decision-analytic model for coronary artery disease prevention with statins. Medical Decision Making 29, 619-633 (2009)
  • Brunner H, Stollenwerk B: Standard-Methoden der gesundheitsökonomischen Bewertung. In: Lauterbach KW, Stock S, Brunner H. Gesundheitsökonomie: Lehrbuch für Mediziner und andere Gesundheitsberufe. 2. Auflage. Verlag Hans Huber, Bern (2009)
  • Stollenwerk B, Brunner H: Weiterführende Methoden. In: Lauterbach KW, Stock S, Brunner H. Gesundheitsökonomie: Lehrbuch für Mediziner und andere Gesundheitsberufe. 2. Auflage. Verlag Hans Huber, Bern (2009)
  • Miksad RA, Zietemann Z, Gothe R, Schwarzer R, Conrads-Frank A, Schnell-Inderst P, Stollenwerk B, Siebert U: Progression-free survival as a surrogate endpoint in advanced breast cancer. International Journal of Technology Assessment in Health Care 24(4), 371–383 (2008)
  • Gerber A, Stollenwerk B, Lauterbach KW, Stock S, Büscher G, Rath T, Lungen M: Evaluation of multi-dose repackaging for individual patients in long-term care institutions: savings from the perspective of statutory health insurance in Germany. International Journal of Pharmacy Practice 16(6), 381-386 (2008)
  • Ramoner R, Rahm A, Gander H, Stollenwerk B, Falkensammer C, Leonhartsberger N, Thurnher M: Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma. Cancer Immunol Immunother 57, 1207-1214 (2008)
  • Stock S, Stollenwerk B, Klever-Deichert G., Redaelli M, Büscher G, Graf C, Möhlendick K, Mai J, Gerber A, Lüngen M, Lauterbach KW: Preliminary analysis of short term financial implications of a prevention bonus program- First Results from the German Statutory Health Insurance. International Journal of Public Health (IJPH) 53, 78-86 (2008)
  • Stock AKS, Stollenwerk B, Redaelli M, Lauterbach KW: Sex differences in treatment patterns of 6 chronic diseases: An analysis from the German statutory health insurance. Journal of Women’s Health 17(3), 343-354 (2008)
  • Lüngen M, Stollenwerk B, Messner P, Lauterbach KW, Gerber A: Waiting times for elective treatments according to insurance status; a randomised empirical study in Germany. Int J Equity Health 7, 1-7 (2008)
    •  

 

back to Team